Polyethylene Gycol 3350 Powder, For Solution
Product Images NDC 69168-473

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Polyethylene Gycol 3350 (NDC 69168-473). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allegiant Health, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Peg 3350 Powder 510g (473 Peg 3350 Powder 1)

This is a product label for HealthA2l® osmotic laxative in powder form. It is designed to relieve occasional constipation or irregularity. The active ingredient is Polyethylene Glycol 3350, and it is recommended to consult a doctor or pharmacist before use, especially if taking other medications. It is crucial to follow dosage instructions, as overuse may lead to side effects such as loose stools. The product dissolves in beverages and is not intended for long-term use without medical advice, especially for individuals with certain health conditions or under 16 years of age.*

FDA Label Image

Peg 3350 Powder 238g (473 Peg 3350 Powder 2)

This is a detailed label of a medication called Miralax, containing Polyethylene Glycol 3350 as the active ingredient. It is an osmotic laxative used to relieve occasional constipation and soften stool. The label includes information on usage, warnings, drug facts, directions for use, and contact information. The product is sugar-free, dissolves in any beverage, and comes with specific measuring instructions for adults and children. It also provides details on temperature storage and handling precautions. The label cautions about allergic reactions, kidney disease, and advises consulting a doctor before use in certain medical conditions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.